wandrews@cooley.com
Wade W. Andrews is a business associate focusing on general corporate law.
Download full bio
Bristol Myers Squibb to Acquire Turning Point Therapeutics for $4.1 Billion
Reneo Pharmaceuticals – $94 Million IPO
Equillium – $65.4 Million IPO
HTG Completes its Initial Public Offering
Horizon Pharma Acquires Hyperion Therapeutics for $1.1 Billion
View all
University of California Hastings College of LawJD, magna cum laude, 2009
Brigham Young University BS, 2005
Turning Point Therapeutics to Sell to Bristol Myers Squibb for $4.1 Billion June 3, 2022
Tocagen – $98 Million IPO April 20, 2017
Horizon Pharma to Buy Raptor Pharmaceutical for $800 Million September 15, 2016
+1 858 550 6042
Locations